Dr Ghia on Efficacy and Safety of Acalabrutinib in RelapsedRefractory CLL

>> DOWNLOAD LINK 🎞️ #1 <<

>> DOWNLOAD LINK 🎞️ #2 <<

>> COPY / PASTE LINK PLEASE 🎵 MP3 <<

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=QVtHqJBC2wI

Paolo Ghia, MD, PhD, a professor of Medical Oncology and the director of the Strategic Research Program on CLL and the B Cell Neoplasia Unit at Università Vita-Salute San Raffaele University, discusses the efficacy and safety of acalabrutinib (Calquence) in the phase 3 ASCEND trial in relapsed/refractory chronic lymphocytic leukemia. • Website: https://www.onclive.com • Twitter:   / onclive   • Facebook:   / onclive   • LinkedIn:   / onclive  

#############################